ConductScience.org, home

Trial · NCT07908238

Registered outcomes14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPercentage of women achieving > 500mls expressed breast milk by 14 days' post-partumfrom enrolment to two weeks post delivery
PrimaryPercentage of women achieving > 500mls by 14 days' post-partum in mothers of preterm infants < 33 weeks gestation and/or 1500 gramMilk amount from time of enrolment to two weeks post delivery
Mothers of preterm infants \<33 weeks and /or 1500 gram will randomly assigned to early breast pumping group or late breast pumping group as outlined above , the primary outcome is the achieving of more than 500 ml of breast milk by day 14 post delivery.
SecondaryParenteral nutrition daysFrom the time of enrolment until 6 weeks post menstrual ageTotal days of parenteral nutrition until reaching to full feed
SecondaryTime to full feedsFrom date of randomization until reaching fullfeedHow many days required to reach full feed
SecondaryDonor milk useFrom the time of enrolment until 6 weeks post menstrual ageThe number of participants who required donor milk from birth until discharge
SecondaryCentral line associated blood stream infectionsFrom the time of enrolment until 6 weeks post menstrual age
The number of participants with any documented central line infection from birth until discharge from hospital .Catheter-related bloodstream infection Clinical signs of sepsis and positive peripheral blood culture in the absence of an obvious source other than CVC with one of the following: Positive semiquantitative (\>15 CFU) or quantitative (\>103 CFU) culture from a part of the catheter with the same organisms isolated peripherally Simultaneous quantitative blood cultures with a ratio of ≥3:1 (CVC vs. peripheral) Time difference of ≤2 hours leading to culture positive between CVC and peripheral cultures. Central line-associated bloodstream infection is primary bloodstream infection in a patient who had a central line within the 48 hours period before development of infection.
SecondaryNecrotising enterocolitisFrom the time of enrolment until 6 weeks post menstrual ageThe number of participants who had any episode of necrotizing enterocolitis as defined by Modified Bell's staging criteria from enrolment to discharge.
SecondaryChronic lung diseaseFrom the time of enrolment until 6 weeks post menstrual ageTotal numbers of days of respiratory support for the participant
SecondaryLate onset sepsisFrom the time of enrolment until 6 weeks post menstrual ageThe number of participants who had any documented late onset sepsis, described as documented infection after 72 hours after birth .
SecondaryBreastfeeding at hospital dischargeFrom the time of enrolment until 6 weeks post menstrual ageThe number of participants involved in the study discharged home on breast feeding
SecondaryDeath before hospital dischargeFrom birth to time and date of deathThe number of participants ,time and cause of death during the study period
SecondaryDuration of hospitalisationFrom date of randomization until the date of discharge homeTo duration in days of hospital stay from birth until discharge from hospital
SecondaryParental attitudes and experiences (interviews with parents to access and enhance family centre care model)From time of birth to discharge from hospital
During study period , we are going to carry out interview with parents on level of education during antenatal period on the use of hospital breast pumping , when and how to access breast pumping device , pain associated with hand expression and breast pumping device . Level of education and support during first weeks after delivery . Added more , we are going to perform eduction sessions to the postnatal and delivery wards staff , NICU staff including Consultants , junior doctors and nursing staff .
SecondaryFormula milkFrom the time of enrolment until 6 weeks post menstrual ageThe number of participants who used of formula milk at any stage after birth until discharge from hospital

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07908238/registered